DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
External link for DIA
DIA reposted this
Physician scientist in translational medicine and early clinical development with experience in tech, biotech pharma, academia and clinical medicine. Specialising in oligonucleotide therapeutics at GSK.
Only 1 day left to secure early bird registration for the DIA/ FDA Oligonucleotide-based Therapeutics Conference (28-30 Oct 2024, Washington DC). It's going to be a great meeting! https://lnkd.in/ed9Ezu3h
Join us online for the Medical Writing of PSUR/PRER Training Course, starting on 15 October. Learn more about best practices in source data collection, essential role of quality checks (QC) during the whole process of report preparation, and critical aspects of medical writing, including data editing and presentation. This live-virtual training course will be hosted by: ◾ Sven Schrip, Head of Global Pharmacovigilance Writing, Boehringer Ingelheim, Germany ◾ Jan Kolouch, CEO, Strategic PV Advisor, NextPV Services s.r.o., Czech Republic Don’t miss this unique opportunity to get a firm knowledge foundation on the medical writing of PSUR/PBRER with hands-on exercises. The early bird rate is ending next week. Register today: https://bit.ly/3yMKPEZ. #Pharmacovigilance #DrugSafety #PSUR #MedicalWriting #Learning
We are counting down the weeks until this year's Real-World Evidence Conference! Our Program Committee has been hard at work to bring you informative, relevant sessions that will allow you translate insights into real-world value. Early Bird rates are available until end of day tomorrow and spots are limited - take advantage and secure your spot today! #RWE24 #RealWorldEvidence #RWE #LifeScience
This content isn’t available here
Access this content and more in the LinkedIn app
The preliminary programme for the 2024 DIA Middle East & North Africa (MENA) Conference is now available! Join us in Cairo, Egypt, on 26-27 November for an unparalleled opportunity to engage with key stakeholders in the pharmaceutical sector. This year’s conference will bring together health authorities, industry leaders, academics, and patient representatives to explore the unique opportunities and challenges in the MENA region. Topics include: ◾ Regional regulatory and reliance developments ◾ Digital transformation, AI and RWE ◾ Rare diseases ◾ Advanced therapies ◾ eLabelling ◾ Supply chain and sample management ◾ And much more! Don’t miss out on this great chance to collaborate, connect, and learn from over 300 participants representing countries across the region. Access the full programme here: https://bit.ly/3yQlcD1. #DIAMENA2024 #PharmaInnovation #HealthcareLeadership #MENARegion #RegulatoryScience
The 2024 DIA India Annual Meeting is right around the corner! This year, we are thrilled to host a lineup of leading experts who will dive into the latest in medical devices, pharmacovigilance, regulatory sciences, and clinical topics. Expect engaging sessions on AI, regulatory challenges, and innovative strategies that will shape the future of healthcare. Connect with top professionals, share insights, and explore new opportunities. Check out our website for the full list of speakers and secure your spot today: https://bit.ly/4bR5YM0. Vinod Mattoo Pravin Nath Dr.Rajesh Kumawat Susan Korah Amrit Gill, MD MBA Anupam Chhabra, MD, MBA Dr Ritu Singal M.D Dr Ashok Swain Nishank Nivedit #DIAIndia #Pharmacovigilance #Clinical #RegulatoryAffairs #MedicalDevices
FREE WEBINAR: EU Combination Products - Opportunities and Challenges Bringing combination products to the European market is a complex endeavor, often hindered by regulatory challenges. These obstacles can stifle innovation, creating significant barriers to market entry. In this session from DIA Europe 2024, experts from the Medical Products Agency, EMA and industry share their insights on the current regulatory hurdles and discuss potential pathways to foster innovation in the European market. Interested in this topic? Watch the full session on-demand and join us at DIA Europe 2025 to continue these critical discussions. ◾ Access the webinar: https://bit.ly/3Xeh60Q. ◾ Learn more about DIA Europe 2025: https://bit.ly/3xbhliT. #DIAEurope #Learning #CombinationProducts #LifeSciences
It's time to elevate your edge this season by connecting, learning, and growing in your expertise at our events across the Americas. Here's what's in the queue for this fall... Global Clinical Trial Disclosure and Data Transparency Conference September 23-24 | Arlington, VA Advance Rates expire today! Latin America Annual Meeting September 25-26 | Brasília, Brazil Real-World Evidence Conference October 24-25 | Philadelphia, PA DIA/FDA Oligonucleotide-based Therapeutics Conference October 28-30 | Washington, DC Canada Annual Meeting November 14-15 | Gatineau, QC View more details ➡ https://lnkd.in/eZ68Eqpq
Don’t miss our FREE QPPV Talks Webinar on 26 September! Join us for an insightful 45-minute webinar featuring Ilaria Grisoni (Jazz Pharmaceuticals) and Gabrielle Amselem (Alexion, AstraZeneca Rare Disease) as they share their expertise on critical pharmacovigilance topics. Get a preview of the key discussions set for the DIA Global QPPV Forum and gain valuable insights into the field. Follow our page for the latest updates and register now to secure your spot! Cláudia Ferreira #QPPVForum2024 #QPPVTalks #Pharmacovigilance #DrugSafety #PSMF
This content isn’t available here
Access this content and more in the LinkedIn app